{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:13:49Z","timestamp":1756253629894,"version":"3.44.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":182,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016289","name":"Taiju Life Social Welfare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hyperuricaemia is a risk factor for gout, kidney diseases, and cerebrovascular diseases. Uric acid (UA) is also known as an antioxidant and has been suggested to inhibit the progression of neurodegenerative diseases, such as Parkinson\u2019s disease. However, only a few studies have focused on the potential effects of UA on the basal ganglia. This study aimed to measure UA levels and basal ganglia volumes in community-dwelling adults and to evaluate the association thereof. Blood UA levels and brain MRI data were collected from individuals who underwent brain health checkups between January 2015 and March 2022 at Shimane Institute of Health Science. Participants were classified into three groups based on their UA levels: normal-low UA (&amp;lt; 5.0\u2005mg\/dL), normal-high UA (5.0\u20137.0\u2005mg\/dL), and hyperuricaemia (&amp;gt; 7.0\u2005mg\/dL). MRI was used to assess the presence of asymptomatic infarcts, microbleeds, and the severity of enlarged perivascular spaces in the basal ganglia. The volumes of the caudate nucleus, globus pallidus, putamen, substantia nigra, and subthalamic nucleus were calculated using voxel-based morphometry (VBM) as Z-scores adjusted for participant age, sex, and total intracranial volume. Analysis of covariance and smooth-curve fitting models were used to examine the association between UA levels and basal ganglia volumes. In total, 981 participants were included in the analysis. Analysis of covariance revealed that the hyperuricaemia group had significantly higher Z-scores (indicating smaller volumes) in the bilateral caudate nucleus head and putamen than those of the normal-high UA group. The smooth-curve model showed U-shaped associations with smaller volumes for both high and low UA levels, whereas piecewise linear regression analysis confirmed significant regression lines only in the group with higher UA levels. Although UA is thought to have a neuroprotective effect in adults, our findings indicate that hyperuricaemia may contribute to smaller volumes in the caudate nucleus head and putamen. This suggests that excessive UA levels could negatively affect basal ganglia structure and neurological health.<\/jats:p>","DOI":"10.1093\/braincomms\/fcaf263","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:15:51Z","timestamp":1751465751000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperuricaemia is associated with smaller volumes in the caudate nucleus head and putamen"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3001-6209","authenticated-orcid":false,"given":"Naoki","family":"Omori","sequence":"first","affiliation":[{"name":"Department of Neurology, Shimane University , Izumo City, Shimane 693-8501 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Research and Development, ERISA Corporation , Matsue City, Shimane 690-0816 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takamura","sequence":"additional","affiliation":[{"name":"Institutional Research Center, Fujita Health University , Toyoake City, Aichi 470-1192 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shimane University , Izumo City, Shimane 693-8501 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shimane University , Izumo City, Shimane 693-8501 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"4","key":"2025082607525412800_fcaf263-B1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.rdc.2022.06.009","article-title":"Environmental triggers of hyperuricemia and gout","volume":"48","author":"Helget","year":"2022","journal-title":"Rheum Dis Clin North Am"},{"issue":"12","key":"2025082607525412800_fcaf263-B2","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1016\/j.numecd.2021.08.043","article-title":"High-level uric acid in asymptomatic hyperuricemia could be an isolated risk factor of cardio-cerebrovascular diseases: A prospective cohort study","volume":"31","author":"Cheng","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2025082607525412800_fcaf263-B3","doi-asserted-by":"crossref","first-page":"828476","DOI":"10.3389\/fpsyt.2022.828476","article-title":"The influence of serum uric acid on the brain and cognitive dysfunction","volume":"13","author":"Mijailovic","year":"2022","journal-title":"Front Psychiatry"},{"issue":"1","key":"2025082607525412800_fcaf263-B4","doi-asserted-by":"crossref","first-page":"16435","DOI":"10.1038\/s41598-017-16715-5","article-title":"Serum uric acid is independently associated with enlarged perivascular spaces","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"2025082607525412800_fcaf263-B5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: Mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2025082607525412800_fcaf263-B6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jalz.2019.01.014","article-title":"Urate and risk of Alzheimer\u2019s disease and vascular dementia: A population-based study","volume":"15","author":"Scheepers","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"1\u20132","key":"2025082607525412800_fcaf263-B7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2009.06.002","article-title":"Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?","volume":"285","author":"Keizman","year":"2009","journal-title":"J Neurol Sci"},{"issue":"9","key":"2025082607525412800_fcaf263-B8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/medicina57090972","article-title":"The influence of serum uric acid level on non-motor symptoms occurrence and severity in patients with idiopathic Parkinson's disease and atypical parkinsonisms-a systematic review","volume":"57","author":"Grazynska","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"11","key":"2025082607525412800_fcaf263-B9","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2025082607525412800_fcaf263-B10","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025082607525412800_fcaf263-B11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.wneu.2019.04.211","article-title":"Value of brain dock (brain screening) system in Japan","volume":"127","author":"Morita","year":"2019","journal-title":"World Neurosurg"},{"issue":"19","key":"2025082607525412800_fcaf263-B12","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"2025082607525412800_fcaf263-B13","first-page":"sp-1-sp-40","article-title":"Japanese society of gout and uric & nucleic acids 2019 guidelines for management of hyperuricemia and gout 3rd edition","volume":"44","author":"Hisatome","year":"2020","journal-title":"Gout Uric Nucleic Acids"},{"issue":"2","key":"2025082607525412800_fcaf263-B14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nprot.2015.014","article-title":"A 12-step user guide for analyzing voxel-wise gray matter asymmetries in statistical parametric mapping (SPM)","volume":"10","author":"Kurth","year":"2015","journal-title":"Nat Protoc"},{"issue":"1","key":"2025082607525412800_fcaf263-B15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"2025082607525412800_fcaf263-B16","doi-asserted-by":"crossref","first-page":"576029","DOI":"10.3389\/fneur.2020.576029","article-title":"Machine learning for diagnosis of AD and prediction of MCI progression from brain MRI using brain anatomical analysis using diffeomorphic deformation","volume":"11","author":"Syaifullah","year":"2020","journal-title":"Front Neurol"},{"issue":"7","key":"2025082607525412800_fcaf263-B17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","article-title":"Neuroimaging standards for research into small vessel disease-advances since 2013","volume":"22","author":"Duering","year":"2023","journal-title":"Lancet Neurol"},{"volume-title":"The Japan brain dock society guideline 2019 (in Japanese)","year":"2019","author":"Katayama","key":"2025082607525412800_fcaf263-B18"},{"key":"2025082607525412800_fcaf263-B19","doi-asserted-by":"crossref","first-page":"1035114","DOI":"10.3389\/fendo.2022.1035114","article-title":"The dose-response relationship between sex hormones and hyperuricemia in different gender: NHANES 2013\u20132016","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2025082607525412800_fcaf263-B20","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.3390\/jcm11102743","article-title":"The association between serum testosterone and hyperuricemia in males","volume":"11","author":"Tsai","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"2025082607525412800_fcaf263-B21","doi-asserted-by":"crossref","first-page":"e56546","DOI":"10.1371\/journal.pone.0056546","article-title":"Dose-response association of uncontrolled blood pressure and cardiovascular disease risk factors with hyperuricemia and gout","volume":"8","author":"Juraschek","year":"2013","journal-title":"PLoS One"},{"key":"2025082607525412800_fcaf263-B22","doi-asserted-by":"crossref","first-page":"5817348","DOI":"10.1155\/2020\/5817348","article-title":"Research advances in the mechanisms of hyperuricemia-induced renal injury","volume":"2020","author":"Su","year":"2020","journal-title":"Biomed Res Int"},{"key":"2025082607525412800_fcaf263-B23","first-page":"165","volume-title":"Clinical methods: The history, physical, and laboratory examinations","author":"Barr","year":"1990","edition":"3rd edn"},{"key":"2025082607525412800_fcaf263-B24","doi-asserted-by":"crossref","first-page":"1038011","DOI":"10.3389\/fnins.2023.1038011","article-title":"The etiology and evolution of magnetic resonance imaging-visible perivascular spaces: Systematic review and meta-analysis","volume":"17","author":"Okar","year":"2023","journal-title":"Front Neurosci"},{"key":"2025082607525412800_fcaf263-B25","doi-asserted-by":"crossref","first-page":"1164756","DOI":"10.3389\/fneur.2023.1164756","article-title":"Uric acid and neurological disease: A narrative review","volume":"14","author":"Otani","year":"2023","journal-title":"Front Neurol"},{"issue":"2","key":"2025082607525412800_fcaf263-B26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ene.14070","article-title":"Gender difference in the effect of uric acid on striatal dopamine in early Parkinson's disease","volume":"27","author":"Oh","year":"2020","journal-title":"Eur J Neurol"},{"issue":"11","key":"2025082607525412800_fcaf263-B27","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/mds.29209","article-title":"Uric acid in Parkinson\u2019s disease: What is the connection?","volume":"37","author":"Seifar","year":"2022","journal-title":"Mov Disord"},{"key":"2025082607525412800_fcaf263-B28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-12-819096-8.00028-8","volume-title":"Uric acid. Antioxidants effects in health","author":"Mahomoodally","year":"2022"},{"issue":"22","key":"2025082607525412800_fcaf263-B29","doi-asserted-by":"crossref","first-page":"12394","DOI":"10.3390\/ijms222212394","article-title":"Uric acid in inflammation and the pathogenesis of atherosclerosis","volume":"22","author":"Kimura","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2025082607525412800_fcaf263-B30","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1038\/s41467-023-38602-6","article-title":"Association of gout with brain reserve and vulnerability to neurodegenerative disease","volume":"14","author":"Topiwala","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"2025082607525412800_fcaf263-B31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/npr2.12445","article-title":"Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective","volume":"44","author":"Alrouji","year":"2024","journal-title":"Neuropsychopharmacol Rep"},{"issue":"1","key":"2025082607525412800_fcaf263-B32","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1038\/s41598-020-63134-0","article-title":"Association between serum uric acid levels and mortality: A nationwide community-based cohort study","volume":"10","author":"Konta","year":"2020","journal-title":"Sci Rep"},{"key":"2025082607525412800_fcaf263-B33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"2025082607525412800_fcaf263-B34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3988\/jcn.2007.3.2.79","article-title":"Use of the putamen\/caudate volume ratio for early differentiation between parkinsonian variant of multiple system atrophy and Parkinson disease","volume":"3","author":"Shin","year":"2007","journal-title":"J Clin Neurol"},{"issue":"1","key":"2025082607525412800_fcaf263-B35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2005.07.013","article-title":"Increased intracranial volume in Parkinson\u2019s disease","volume":"239","author":"Krabbe","year":"2005","journal-title":"J Neurol Sci"},{"issue":"12","key":"2025082607525412800_fcaf263-B36","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1474-4422(13)70238-2","article-title":"Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: A cross-sectional study","volume":"12","author":"Schretlen","year":"2013","journal-title":"Lancet Neurol"},{"issue":"24","key":"2025082607525412800_fcaf263-B37","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1056\/NEJM199606133342403","article-title":"Presynaptic dopaminergic deficits in Lesch-Nyhan disease","volume":"334","author":"Ernst","year":"1996","journal-title":"N Engl J Med"},{"issue":"11","key":"2025082607525412800_fcaf263-B38","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1073\/pnas.93.11.5539","article-title":"Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo","volume":"93","author":"Wong","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2\u20133","key":"2025082607525412800_fcaf263-B39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0165-0173(99)00094-6","article-title":"Lesch-Nyhan disease and the basal ganglia","volume":"32","author":"Visser","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"volume-title":"Lacunar syndromes (archived)","year":"2025","author":"Venkataraman","key":"2025082607525412800_fcaf263-B40"},{"issue":"3","key":"2025082607525412800_fcaf263-B41","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hbm.25715","article-title":"Basal ganglia atrophy-associated causal structural network degeneration in Parkinson's disease","volume":"43","author":"Li","year":"2022","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"2025082607525412800_fcaf263-B42","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/biomedicines10030652","article-title":"Hypouricemia and urate transporters","volume":"10","author":"Otani","year":"2022","journal-title":"Biomedicines"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcaf263\/63648671\/fcaf263.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/4\/fcaf263\/63648671\/fcaf263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/4\/fcaf263\/63648671\/fcaf263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:53:00Z","timestamp":1756209180000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcaf263\/8182684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcaf263","relation":{},"ISSN":["2632-1297"],"issn-type":[{"type":"electronic","value":"2632-1297"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"fcaf263"}}